Our Research

Our Research

>> Research Departments
>> Find Clinical Trials
>> Our Publications
>> Our Research Collaborations


Contact Details

  Street address:
Level 11, KGV Building
Missenden Road
CAMPERDOWN NSW 2050
 
Postal address:
Post Office Box M30
Missenden Road NSW 2050

Phone: (02) 9515-6111
Fax: (02) 9515-9610

Online Feedback

Cardiothoracic Surgery

Our Research

Our Cardiothoracic surgeons and interventionalists are amongst the best in the world; this is especially true at RPAH, where, through the Baird Institute and the new Institute of Academic Surgery, they have led a dramatic research-centric culture shift over the past decade. More than half of the research published in the field of Cardiothoracic Surgery in Australia and New Zealand in the last five years has emanated from this precinct. Amongst many other positions held, its surgeons head the Australian and New Zealand Society of Cardiac and Thoracic Surgeons and the National Cardiothoracic Surgical Research Network.vInternationally the Cardiothoracic surgeons of RPAH and the Baird are well recognised with existing collaborations with Oxford and Stanford Universities as well as many other major clinical institutions.

The RPAH Cardiothoracic Surgery Department in conjunction with The Baird Institute is conducting and assisting research that directly benefits cardiothoracic surgical patients in the areas of new materials for heart valves, best practice management of asbestos-related surgical disease, improved surgical techniques, the use of stents, balloons and patches, drug therapies and the use of a patient support group to improve peri-operative and post-surgery quality of life.

These multimodal areas of research are described under the following:

  1. Aortic Disease Research.
    Thoracic aortic aneurysm disease is rapidly becoming one of the most common but silent killers in western society. Many conditions are inherited including Marfan's disease, and those conditions associated with abnormal heart valves. Our research is aimed at determining the precise genetic basis of the condition, the mechanisms leading to the changes in the aorta, and developing peripheral tests to detect enlargement of the aorta and imminent rupture. The Aortic Valve Disease Group has strengthened ties with The Centenary Institute and continues to investigate issues of abnormal heart valves or enlargement of the Aorta. Database information has been developed to monitor genetic and familial representations of these diseases, which in clinical practice is used to help determine how these killer conditions are inherited. The goal is to determine when surgical intervention is optimal or at the lowest risk time for the patient. We are affiliated with the Collaborative Research (CORE) Group, responsible for establishing and organizing the world's largest multi-institutional Aortic ARCH Registry, consisting of 14,000 patients from 37 leading aortic centers from 11 countries.
     
  2. Biomaterials
    Many different devices are now implanted surgically to repair or improve the function of the heart. These devices, including artificial blood vessels and heart valves, are inserted with minimal risk. However, many are not biocompatible. They may be seen as foreign objects by the body, and may require life-long blood thinning medication, which carries its own burden of disease. Thus, our research is aimed at producing biocompatible devices by electromagnetically coating foreign surfaces with recombinant synthetic human elastin and fibronectin. This technique is currently being developed to build new blood vessels in the laboratory. As biocompatibility is demonstrated, the technology and knowledge gained may be used to produce other biocompatible devices. Past fellow and current surgeon, Dr. Michael Byrom is commencing further laboratory-based research in conjunction with Associate Professor Martin Ng (Heart Research Institute) and is working with current students, to continue work on new materials and coatings in novel vascular bypass conduits. Laboratory studies will take place at The Charles Perkins Centre, RPAH, which provides a first-class facility for in-vivo training, testing and assessment of new vascular biomaterial implants including valves, stents, and conduits. Outcomes from this work include the development of a biocompatible 'off-the-shelf' blood vessel for use in patients when the patient's own blood vessels are not suitable or appropriate to the surgery.
     
  3. Innovative Heart Surgery
    Heart surgery in our aging population presents us with unique difficulties, challenges and opportunities. Our research aims to improve the survival and quality of life of the higher risk cardiac patient through the development of novel surgical techniques and strategies, investigating the specific interactions between the heart-lung machine and the body in the laboratory, and determine the optimum approach for each individual patient through meta-analysis. A major impact from this research is to decrease the incidence of stroke during cardiac surgery; as well as to reduce the impact of an artificial heart and blood oxygen machine upon the patient's intra-operative and post-operative recovery. In addition to these anticipated outcomes, further research is being conducted to confirm or alter the advantages between the uses of coronary surgery versus coronary stenting.
     
  4. Thoracic Oncology Group
    Research understanding has been progressed within the areas of lung cancer, mesothelioma, surgical correction and life extension at The Baird for over 10 years. Our researchers have coordinated a planned approach to the surgical management of patients with these devastating cancers and have built an international reputation for excellence in surgical results and within total patient care. Research into early detection and surgical management are making some inroads into improving patient outcomes. We are affiliated with the VATS Lobectomy Consensus Group, involving 50 world experts in Minimally Invasive Thoracic Surgery.

Key Achievements

  1. Commencement at RPAH of the Vision cardiac surgery study

    The VISION Cardiac Surgery Study will establish the role of perioperative hsTnI measurements in identifying prognostically important myocardial injury after cardiac surgery and the proportion that would go undetected without routine troponin monitoring. This, in turn, will facilitate further studies of timely interventions. This cohort study will also determine the current incidence of major perioperative vascular events in a representative sample of contemporary adult patients undergoing cardiac surgery. 246 patients have been recruited at RPAH with a world-wide goal of 15,000 patients. The study aims to determine the relationship between postoperative high-sensitivity Troponin I measurements and the 30-day risk of mortality, the proportion of perioperative myocardial injuries that may go undetected without perioperative troponin monitoring, and the incidence of major vascular complications after surgery.
     
  2. Setting up the foundation of, in conjunction with the RPAH anaesthetic department, a research program to study the Effect of ECMO on end-organ perfusion

    Extra-corporeal membrane oxygenation (ECMO) is used to provide cardiovascular and respiratory support of patients with severe respiratory disorders. It is an external circuit that drains the patient's blood, oxygenates it through an artificial lung before returning the blood to the patient. This allows the patient's lungs and heart to rest. Veno-arterial (VA) ECMO involves draining deoxygenated blood from the right atrium (via femoral vein cannulation) into a centrifugal pump and oxygenator, before returning oxygenated blood to the patient's circulation via the femoral artery, at a rate of approximately 4 L/min. Whilst this can help greatly with supporting critically ill patients, the effects of the ECMO circuit on end-organ perfusion is relatively unknown.

    VA ECMO pushes flow up the descending aorta, in the reverse direction to normal flow. If the patient has some residual heart function, this retrograde flow mixes with native heart flow, with the effect on end organ perfusion unknown. The research question is to identify the differences in end organ perfusion (particularly kidneys and stomach/intestines) between a healthy person, an ECMO patient with no heart function and a recovering ECMO patient with some heart function. This information will then be used to determine optimal ECMO flow conditions for a range of residual heart functions. This project will be conducted in collaboration with researchers from Royal Prince Alfred Hospital, Sydney Translational Imaging Laboratory at the University of Sydney and the Graduate School of Biomedical Engineering at University of New South Wales.

    To meet the project aim, 3D models of the descending aorta (including femoral arteries) will be created and validated using 4D-Flow MRI data. An ECMO patient will then be simulated, and ECMO flow rates set between 0 and 4L/min, in order to determine the optimal level of support for suitable end organ perfusion. The study will be repeated for a recovering ECMO patient.

    Models will be validated using a silicone re-creation of the descending aorta. Patient flows will be recreated using a MRI-compatible mock circulation loop. 4D flow images will be recorded for all three different flow conditions (healthy, full ECMO support, partial ECMO support) and compared to the results produced by the model.
     
  3. The initiation of, in collaboration with the Charles Perkins Centre at the University of Sydney, a Translational research Facility.

    The model for this facility includes a hybrid imaging system a coupled MRI suite, as well as the only Robotic training facility in the southern hemisphere. A hybrid surgical approach involves the integrated use of imaging, percutaneous and invasive surgical techniques to perform minimally invasive surgical techniques with greater precision, maximising outcomes and minimising damage to patients. A hybrid procedural approach emphasises multidisciplinary care, and typical hybrid procedures involve proceduralists from a number of different specialties. The cross-disciplinary nature of the hybrid approach highlights a unifying role for the Facility as a place where engineers, computer scientists, physiologists, molecular scientists and clinicians will collaborate. Invasive measurements of physiology, cell and molecular biology, and immunology are vitally important in conditions as varied as heart failure, atherosclerosis, valve stenosis, cardiomyopathy, peripheral vascular disease and metabolic diseases. We envisage a broad scientific role for the facility that will extend well beyond the interventions that are practiced clinically - including refinement of biosynthetic vessels, development of new percutaneous devices, validation of non-invasive imaging tests, in vivo measurements of clotting and endothelial dysfunction and basic science experiments involving delivery of percutaneous stem cells or pharmacological agents.

    Complementary to the hybrid approach is the use of both robotic surgical techniques and the integrated use of high-end imaging such as MRI to guide procedures. RPAH has been at the forefront of the adoption of robotic surgery, and in 2015 plans were well in place for the SLHD to provide RPAH with of the latest generation Da Vinci Robotic system The Cardiothoracic surgery department was also making plans in 2015 to submit an ethics proposal in early 2016 to use the Davinci robot in Coronary artery bypass graft surgery.

Research Staff

  • Professor Paul Bannon
    Head of Research, Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Camperdown, NSW. Chairman, The Baird Institute for Applied Heart and Lung Surgery,Newtown, NSW.Advanced Scholar, Macquarie University, NSW.Professor, Chair of Cardiothoracic Surgery,University of Sydney, NSW.
     
  • Professor Michael Vallely, Cardiothoracic surgeon, Chair of Structural Heart
  • Dr Michael Byrom, Cardiothoracic Surgeon
  • Professor Michael Wilson, Cardiothoracic Surgeon.
  • Professor Tristan Yan, Cardiothoracic Surgeon
  • Dr Matthew Bayfield, Cardiothoracic Surgeon
  • Ms Lisa Turner, Cardiovascular Surgery Research CNC
  • Ms Lorna Beattie, Cardiovascular Clinical Trial Coordinator

Higher Degree Students:

PhD:

  • Dr Vikrant Dhurander
  • Dr Andrew Sherrah
  • Dr Michael Secco
  • Dr Roneil Parikh

Masters:

  • Ms Lauren McCann MBBS (MPhil)


Publications and Presentations

Publication Details:
  1. Edelman JJ & Vallely MP (2015). Anaortic OPCAB for High-risk Patients. Heart, Lung and Circulation. 24(2):206
  2. Dhurandhar V, Saxena A, Parikh R, Vallely MP, Wilson MK, Butcher JK, Black DA, Tran L, Reid CM and Bannon PG. (2015). Outcomes of on-pump versus off-pump coronary artery bypass graft surgery in the high risk (AusSCORE>5). Heart, Lung and Circulation.24(12):1216-1224.
  3. Bannon PG, Qasabian R, Byrom MJ. 2015 Pig model gets to the dogma. J Thorac Cardiovasc Surg 150(2):415-416.
  4. Seco M, Martinez G, Edelman JJB, Ng HKB, Vallely MP, Wilson MK, Ng MK. 2014 Combined total-arterial off-pump coronary artery bypass grafting and transaortic transcatheter aortic valve implantation. Int J Cardiology. Apr 14
  5. Dhurandhar V, Parikh R, Saxena A, Vallely MP, Wilson MK, Black DA, Tran L, Reid C and Bannon PG. 2015. Early and late outcomes following valve sparing aortic root reconstruction: The ANZSCTS database. Heart, Lung and Circulation. 24(S1)e16-e17.
  6. Lowe HC and Bannon PG. 2015. Seeking outcomes in database analyses: The good, the bad and the ugly. Int J Cardiology. 202:796.
  7. Bannon PG, Qasabian R and Byrom MJ. 2015. Pig model gets to the dogma. J Thorac Cardiovasc Surg. 150(2):415-416.
  8. Padang R, Bagnall RD, Tsoutsman T, Bannon PG. (2015). Comparative transcriptome profiling in human bicuspid aortic valve disease using RNA-sequencing. Physiol Genomics. 47(3):75-87
  9. Verrelli DI, Qian Y, Wood J and Wilson MK. 2015 Measurement of tremor transmission during microsurgery. Int J Med Robot. 9 Dec 15
  10. Edelman JJ, Tatoulis J, Hayward PA, Smith JA, Costa RJ, Vallely MP and Bannon PJ. 2015. ANZSCTS Response to the Discussion Paper: Proposed recommendations for mycoardial revascularisation. Heart, Lung and Circulation 24(7):646-648.
  11. Saxena A, Newcomb AE, Dhurandhar V and Bannon PG. 2016. Application of clinical databases to contemporary cardiac surgery practice: Where are we now? Heart, Lung and Circulation. 25(3):237-42.
  12. Seco M, Edelman JB, Van Boxtel B, Forrest P, Byrom MJ, Wilson MK, Fraser J, Bannon PG and Vallely MP. (2015). Neurologic injury and protection in adult cardiac and aortic surgery. Journal Cardiothoracic and Vascualar Anesthesia. 29(1):185-195
  13. Virk SA, Bowman SR, Chan L, Bannon PG, Aty W, French BG and Saxena A. 2015. Equivalent outcomes after coronary artery bypass graft surgery performed by consultant versus trainee surgeons: A systematic review and meta-analysis. J Thorac Cardiovasc Surg. 11 Nov 2015
  14. Callaghan FM, Kozor R, Sherrah AG, Vallely M, Celermajer D, Figtree GA and Grieve SM. (2016) Use of multi-velocity encoding 4D flow MRI to imorve quantification of flow patterns in the aorta. J Magn Reson Imaging. 43(2):352-363.
  15. Williams M, Kirschner MB, Cheng YY, Hanh J, Weiss J, Mugridge N, Wright CM, Linton A, Kao SC, Edelman JJ, Vallely M, McCaughan BC, Cooper W, Klebe S, Lin RC, Brahmbhatt H, MacDiarmid J, van Zandwijk N and Reid G. 2015. miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma. Oncotarget 6(27):23480-23495.
  16. Walters DL, Webster M, Pasupati S, Walton A, Muller D, Stewart J, Willaims M, MacIsaac A, Scalia G, Wilson M, El Gamel A, Clarke A, Bennetts J and Bannon P. 2015. Position statement for the operator and instituitional requirements for a transcatheter aortic valve implantation (TAVI) program. Heart, Lung and Circulation 24(3):219-223
  17. Robinson BM, Paterson HS, Naidoo R, Dhurandhar V and Denniss AR. 2015. Bilateral internal thoracic artery composite Y grafts: Analysis of 464 angiograms in 296 patients. Ann Thorac Surg.
  18. Dhurandhar V, Saxena A, Parikh R, Vallely MP, Wilson MK, Butcher JK, Black DA, Tran L, Reid CM and Bannon PG. 2015. Comparison of the safety and efficacy of on-pump (ONCAB) versus off-pump (OPCAB) coronary artery bypass graft surgery in the elderly: a review of the ANZSCTS database. Heart, Lung and Circulation. 24(12):1225-1232
  19. Sherrah AG, Grieve SM, Jeremy RW, Bannon PG, Vallely MP and Puranik R. 2015 MRI in chronic aortic dissection: a systematic review and future directions. Frontiers in Cardiovascular Medicine. 2:1-8.
  20. Wu JJ, Seco M, Medi C, Semsarian C, Richmond DR, Dearani JA, et al. 2015 Surgery for hypertrophic cardiomyopathy. Biophys Rev. 7:117-125.
  21. Kirschner MB, Pulford E, Hoda MA, Rozsas A, Griggs K, Cheng YY, Edelman JJ, Kao SC, Hyland R. Dong Y, László V, Klikovits T, Vallely MP, Grusch M, Hegedus B, Dome B, Klepetko W, van Zandwijk N, Klebe S and Reid G. 2015. Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis. Br J Cancer. 11 Aug.
  22. Padang R, Ganigara M, O'Meagher S, Grieve SM, Bannon PG, Celermajer DS, Jeremy R, Semsarian C and Puranik R. 2015. Feasibility of using real-time CMR imaging to evaluate acute thoracic aortic response to exercise. Int J Cardiology. 197:306-308
  23. Callaghan FM, Karkouri J, Broadhouse K, Evin M, Fletcher DF and Grieve SM. 2015. Thoracic aortic aneurysm: 4D flow MRI and computational fluid dynamics model. Comput Methods Biomech Biomed Engin. Suppl 1:1894-1895
  24. Byrom MJ, Sivakumaran Y, Vallely, MP, Wilson MK and Bannon PG. 2015. How many sutures should a sutureless valve need? J Thorac Cardiovasc Surg. 149(4):1058-1059
  25. Lal S, Li A, Allen D, Allen PD, Bannon P, Cartmill T, Cooke R, Farnsworth A, Keogh A, Dos Remedios C. 2015. Best practice biobanking of human heart tissue. Biophys Rev. 7(4):399-406.
  26. Cheng YY, Wright CM, Kirschner MB, Williams M, Sarun KH, Sytnyk V, Leshchynska I, Edelman JJ, Vallely MP, McCaughan BC, Klebe S, van Zandwijk N, Lin RC and Reid G. 2016. KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma. Mol Cancer. 15(1):44
  27. Verrelli DI, Qian Y, Wilson MK, Wood J and Savage C. 2016. Intraoperative tremor in surgeons and trainees. Interactive Cardiovasc Thorac Surg. 1-6
  28. Seco, M., Edelman, J.J.B., Boxtel, B.V., Forrest, P., Byrom, M, Wilson, M.K., Fraser, J., Bannon, P.G., Vallely, M.P. (2015) Neurological injury and protection in adult cardiac and aortic surgery. Heart, Lung and Circulation. 24(1):e41-42.
  29. Cao, C., Bannon, P., McCaughan, B., Akhunji, Z., Yan., T.D. (2015) Surgical management of malignant pleural mesothelioma. Heart, Lung and Circulation. 24:e68.
  30. Parikh, R.N., Dhurandhar, V., Chan, L.C.K., Vallely, M.P., Wilson, M.K., Byrom, M.J., Bannon, P.G. (2015) Predictors of mortality and stroke in patients undergoing aortic valve replacement using EuroSCORE II. Heart, Lung and Circulation. 24(1):e33.
  31. Seco, M., Cao, C., Modi, P., Bannon, P.G., Wilson, M.K., Vallely, M.P., Misfield, M., Mohr, F., Yan, T.D. (2015) Systematic review of robotic mitral valve surgery. Heart, Lung and Circulation. 24(1):e42-43.
  32. Cao C, Virk SA, Tian DH, Wolfenden H, Yan TD. Is transcatheter aortic valve implantation as cost-effective as surgical aortic valve replacement? Am J Cardiol. 2015 Sep 15;116(6):996-7.
  33. Cao C, Chandrakumar D, Gupta S, Yan TD, Tian DH. Could less be more?-a systematic review and meta-analysis of sublobar resections versus lobectomy for non-small cell lung cancer according to patient selection. Lung Cancer, 2015 Aug;89(2):121-32. doi: 10.1016/j.lungcan.2015.05.010.
  34. Cao C, Dian B, Hendel PN, Yan TD. An unusual cause of pneumonia. Lancet Oncol. 2015 Aug;16(8):e370-1.
  35. Phan K, Wong S, Phan S, Ha J, Qian P, Yan TD. Early hemodynamic performance of the third generation St Jude Trifecta aortic prosthesis: A systematic review andmeta-analysis. J Thorac Cardiovasc Surgery. 2015 Jun;149(6):1567-75.e1-2.
  36. Ha HS, Wang N, Wong S, Phan S, Liao J, Kumar N, Qian P, Yan TD, Phan K. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy patient: a systematic review. J Interv Card Electrophysiol. 2015 Aug 25.
  37. Xie A. Phan K, Tsai YC, Yan TD, Forrest P. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest: a meta-analysis. J Cardiothorac Vasc Anesth. 2015 Jun;29(3):637-45.
  38. Phan K, Phan S, Yan TD. How firm is the evidence for miniaturized extracorporeal circulation versus conventional cardiopulmonary bypass for coronary revascularization? A trial sequential analysis. Int J Cardiol. 2015 Aug 11;201:422-23.
  39. Phan K, Wong S, Wang N, Phan S, Yan TD. Hybrid coronary revascularization versus coronary artery bypass surgery: Systematic review and meta-analysis. Int J Cardiol. Jan 20;179:484-8.
  40. Phan K, Wong S, Phan S, Yan TD. Early outcomes of isolated transcatheter aortic valve implantation versus combined with percutaneous coronary intervention. Int J Cardiol. 2015 Jan 20;179:258-61.
  41. Wang N, Zhou JJ, Phan S, Yan TD, Phan K. Robot-assisted hybrid coronary revascularisation: systematic review. Heart Lung Circ .2015 Jul 14.
  42. Phan K, Phan S, Thiagalingam A, Medi C, Yan TD. Thoracoscopic surgical ablation versus catheter ablation for atrial fibrillation. Eur J Cardiothorac Surg. 2015 May 23. pii: ezv180.
  43. Phan K, Yan TD. Minimally invasive Cox-maze procedure, beating-heart epicardial ablation, hybrid procedure and catheter ablation: a call for comparative evidence. Eur J Cardiothorac Surg. 2015 Sep;48(3):515.
  44. Phan K, Ha Hs, Pahn S, Medi C, Thomas SP, Yan TD. New-onset atrial fibrillation following coronary bypass surgery predicts long-term mortality: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2015 Jan 18. pii: ezu551.
  45. Phan K, Xie A, Kumar N, Wong S, Medi C, La Meir M, Yan TD. Comparing energy sources for surgical ablation of atrial fibrillation: a Bayesian network meta-analysis of randomized, controlled trials. Eur J Cardiothorac Surg. 2015 Aug;48(2):201-11.
  46. Tsai YC, Phan K, Munkholm-Larsen S, Tian DH, La Meir M, Yan TD. Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta-analysis. Eur J Cardiothorac Surg. 2015 May;47(5):847-54.
  47. Cao C, Wolfenden H, Liou K, Pathan F, Gupta S, Nienaber TA, Chandrakumar D, Indraratna P, Yan TD. A meta-analysis of robotic vs conventioinal mitral valve surgery. Ann Cardiothorac Surg. 2015 Jul;4(4):305-14.
  48. Phan K, Croce B, Yan TD. Minimally invasive aortic valve replacement. Ann Cardiothorac Surg. 2015 Mar;4(2):218.
  49. Yan TD. Mini-Bentall procedure and hemi-arch replacement. Ann Cardiothorac Surg. 2015 Mar;4(2):208-9.
  50. Yan TD. Mini-Bentall procedure. Ann Cardiothorac Surg. 2015 Mar;4(2):182-90.
  51. Di Eusanio M. Phan K, Bouchard D, Carrel TP, Dapunt OE, Di Bartolomeo R, Eichstaedt HC, Fischlein T, Folliguet T, Gersak B, Glauber M, Haverich A, Misfeld M, Oberwalder PJ, Santarpino G, Shrestha ML, Solinas M, Vola M, Alamanni F, Albertini A, Bhatnagar G, Carrier M, Clark S, Collart F, Kappert U, Kocher A, Meuris B, Mignosa C, Ouda A, Pelletier M, Rahmanian PB, Reinede D, Teoh K, Troise G, Villa E, Wahlers T, Yan TD. Ann Cardiothorac Surg. 2015 Mar;4(2):131-9.
  52. Phan K, Tian DH, Cao C, Black D, Yan TD. Systematic review and meta-analysis: techniques and a guide for the academic surgeon. Ann Cardiothorac Surg. 2015 Mar;4(2):112-22.
  53. Phan K, Tsai YC, Niranjan N, Bouchard D, Carrel TP, Dapunt OE, Eichstaedt HC, Fischlein T, Gersak B, Glauber M, Haverich A, Misfeld M, Oberwalder PJ, Santarpino G, Shrestha ML, Solinas M, Vola M, Yan TD, Di Eusanio M. Sutureless aortic valve replacement: a systematic review and meta-analysis. . Ann Cardiothorac Surg. 2015 Mar;4(2):100-11.
  54. Phan K, Zhou JJ, Niranjan N, Di Eusanio M, Yan TD. Minimally invasive reoperative aortic valve replacement: a systematic review and meta-analysis. Ann Cardiothorac Surg. 2015 Jan;4(1):15-25.
  55. Phan K, Xie A, Tsai YC, Black D, Di Eusanio M, Yan TD. Ministernotomy or minithoracotomy for minimally invasive aortic valve replacement: a Bayesian network meta-analysis. Ann Cardiothorac Surg. 2015 Jan;4(1):3-14.
  56. Xie A, Phan K, Yan TD. Durability of continuous-flow left ventricular assist devices: a systematic review. Ann Cardiothorac Surg. 2014 Nov;3(6):547-56.

Presentations:

Professor Paul Bannon

  1. 'The Baird Institute and its role in Cardiac Research' Cardiac nurses Education Day, hosted by St Jude Medical, Lane Cove West.
  2. 'Monitoring Outcomes Using a National Database: The Australian and New Zealand Experience'23rd Annual Meeting of the Asian Society for Cardiovascular and Thoracic Surgery, Hong Kong Convention and Exhibition Centre, Hong Kong.
  3. 'Blood conservation strategies in aortic surgery' 23rd Annual Meeting of the Asian Society for Cardiovascular and Thoracic Surgery, Hong Kong Convention and Exhibition Centre, Hong Kong.
  4. 'Role Of Topical Haemostatic Agents In Blood Conservation'Royal Australasian College of Surgeons Annual Scientific Congress 2015, Perth Convention and Exhibition Centre, Perth, WA.
  5. 'Valvular Disease and Management' Year 3 Surgery Lecture, Sydney Medical School, University of Sydney, Camperdown, NSW.

Professor Tristan Yan

  1. Yan TD. Minimally Invasive Aortic Surgery - The Mini-Bentall Procedure. The Liverpool Aortic Symposium VI. Liverpool UK; June 26-27, 2015.
  2. Yan TD. The Arch Projects Update. The Liverpool Aortic Symposium VI. Liverpool UK; June 26-27, 2015.
  3. Yan TD. Minimally Invasive Aortic Surgery - The Mini-Bentall Procedure. SCTS Annual Meeting and Cardiothoracic Forum 2014, Manchester UK, March 25-27, 2015
  4. Yan TD. The Arch Projects Update. SCTS Annual Meeting and Cardiothoracic Forum 2014, Manchester UK, March 25-27, 2015

Contact details for department

Head of Department: Professor Paul Bannon

Department/Unit: Cardiothoracic Surgery
Address:
Other
Level 6 West, Royal Prince Alfred Hospital
Camperdown NSW 2050
Telephone: (02) 9515 6377
Facsimile: (02) 9515 8629
Web: http://www.slhd.nsw.gov.au/research/
Email: lisa.turner@email.cs.nsw.gov.au